Encouraged by quick recovery after kidney cancer

Diagnosed with kidney cancer after multiple abdominal surgeries, cryoablation allowed David to get back to the life he loves.

Read David's story

Press Releases
Apr 26, 2026
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and...

Apr 15, 2026
Boston Scientific announces €75 million investment to expand R&D capabilities in Galway

GALWAY, Ireland, 15 April 2026 - Boston Scientific Corporation (NYSE: BSX) – a global leader in medical device technology – today announced a €75 million investment in its Galway site,...

Mar 28, 2026
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial...

Read more press releases

In the News
Apr 8, 2026
Pulsed field ablation for cardiac arrythmias: innovating for the future
Hospital Healthcare Europe
Pulsed field ablation is emerging as a promising innovation in the treatment of cardiac arrhythmias. By offering a more targeted approach with the potential for improved safety and efficiency, the technology represents a significant step forward in the evolution of electrophysiology care.
Mar 19, 2026
A new era for kidney cancer care?
Health Tech World
Advances in technology and treatment approaches are ushering in a new era for kidney cancer care. From earlier detection to more targeted therapies, innovation is reshaping how the disease is managed and offering new hope for improved patient outcomes.
Mar 18, 2026
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Medical Device Network
Sacral neuromodulation is expanding treatment options for patients with bladder and bowel dysfunction, reinforcing Boston Scientific’s growing urology portfolio in Europe. The therapy highlights the company’s focus on innovative solutions that address unmet clinical needs and improve quality of life.
Feb 18, 2026
What is ureteroscopy and how does it help in treating kidney stones?
Hospital Healthcare Europe
Ureteroscopy is becoming an increasingly important minimally invasive approach for the treatment of kidney stones. By allowing precise visualisation and targeted intervention, it offers an effective alternative to more invasive procedures, helping improve patient outcomes and recovery times.

Read more news

2024 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

Media centre

Imagery and other resources

Top